Evidence map›Paper›PMID 30066574›Full record

ReviewJournal of diabetes science and technology2019

Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring.

Nicole Ehrhardt, Enas Al Zaghal

3 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of diabetes science and technology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05121844 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform: Comprehensive Weight Optimization Program and Customized Lifestyle Modifications

TypeinterventionalSponsorSignos IncRan2021 to 2027Enrolled31,187ConditionsWeight Loss, Metabolic Syndrome, Pre-diabetes, Central ObesityArmsContinuous Glucose Monitor Device
NCT05874635 naactive not recruitingnot on this mapstarted 2023, after this paper: background citation

Use of Signos mHealth Platform in Participants With Non-Insulin Dependent Type 2 Diabetes: Weight and Blood Glucose

TypeinterventionalSponsorSignos IncRan2023 to 2029Enrolled20,000ConditionsWeight Loss, Metabolic Syndrome, Diabetes Mellitus, Type 2, Central ObesityArmsContinuous Glucose Monitor Device
NCT06214221 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

A Randomized Controlled Trial Evaluating the Safety and Effectiveness of the Intelligently-Driven Signos System for Personalized Weight Management in Overweight and Obese Adults

TypeinterventionalSponsorSignos IncRan2024 to 2026Enrolled380ConditionsOverweight and Obesity, Metabolic Syndrome, Weight LossArmsSignos System, Standard Lifestyle Education
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Practical Approaches to Continuous Glucose Monitoring in Primary Care: A UK-Based Consensus Opinion.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nicole Ehrhardt1 Division of Endocrinology, George Washington University, Washington, DC, USA.ORCID 0000-0003-1813-0789
Enas Al Zaghal1 Division of Endocrinology, George Washington University, Washington, DC, USA.
George Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real-time continuous glucose monitoring (RT-CGM) provides real time glucose readings to participants wearing the device. The ability to see changes in glucose has the potential to provide immediate feedback to users on food choices and physical activity. The National Diabetes Prevention Program is currently the only reimbursable intervention for diabetes prevention and weight loss. The purpose of this article is to review the CGM literature on measurements other than Hemoglobin A1c (HbA1c) changes and hypoglycemia and discuss RT-CGM potential use as a behavior modification tool for lifestyle changes and weight reduction in people with prediabetes and type 2 diabetes (T2D).

Indexed as

Blood Glucose Self-MonitoringHealth BehaviorHealthy LifestyleRisk Reduction BehaviorBlood GlucoseDiabetes Mellitus, Type 2Diet, HealthyExerciseFeeding BehaviorGlycated HemoglobinHealth Knowledge, Attitudes, PracticeHumansPrediabetic StatePredictive Value of TestsTreatment OutcomeWeight LossBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humancontinuous glucose monitoringdiabeteslifestyleweight reduction

Identifiers

PMID30066574
PMCPMC6399786
OpenAlexW2885121350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.